| Jun 4, 2026 | finance.yahoo.com | SciSparc: Subsidiary NeuroThera Labs Completed Acquisition of CliniQuantum |
| Jun 3, 2026 | finance.yahoo.com | NeuroThera Labs Inc. Announces Closing of Acquisition of Majority Stake in CliniQuantum Ltd. |
| May 28, 2026 | finance.yahoo.com | SciSparc: Subsidiary NeuroThera Labs Received Conditional Regulatory Approval for Acquisition of CliniQuantum |
| Mar 16, 2026 | finance.yahoo.com | NeuroThera Labs - Clearmind Medicine Collaboration Leads to Patent Application for Depression Therapy |
| Mar 16, 2026 | finance.yahoo.com | SciSparc: NeuroThera Labs- Clearmind Medicine Collaboration Leads to Patent Application for Depression Therapy |
| Mar 13, 2026 | finance.yahoo.com | Clearmind Medicine Announces Hong Kong Patent Filing for Depression Therapy |
| Mar 12, 2026 | finance.yahoo.com | SciSparc: NeuroThera Labs Announces Publication of International Patent in Collaboration with Clearmind Medicine for Novel Therapy Targeting Weight Loss and Fatty Liver Disease |
| Mar 11, 2026 | finance.yahoo.com | NeuroThera Labs Announces Publication of International Patent in Collaboration With Clearmind Medicine for Novel Therapy Targeting Weight Loss and Fatty Liver Disease |
| Mar 10, 2026 | finance.yahoo.com | Neurothera Labs Inc. Announces Definitive Agreement to Acquire Majority Stake in Cliniquantum Ltd. |
| Mar 10, 2026 | finance.yahoo.com | SciSparc: Subsidiary NeuroThera Labs (75%) Signs Definitive Agreement to Acquire Majority Stake in CliniQuantum, Innovator in Quantum-based Clinical trails |
| Mar 10, 2026 | finance.yahoo.com | Clearmind Medicine Announces Publication of International Patent for Novel Therapy Targeting Weight Loss and Fatty Liver Disease |
| Mar 3, 2026 | finance.yahoo.com | SciSparc announces 1-for-9 reverse share split |
| Mar 2, 2026 | finance.yahoo.com | SciSparc Announces 1-for-9 Reverse Share Split |
| Feb 2, 2026 | finance.yahoo.com | Neurothera Labs Granted U.S. Patent for Cannabinoid Technology to Overcome Antimicrobial Resistance Such as MRSA |
| Feb 2, 2026 | finance.yahoo.com | SciSparc: NeuroThera Labs Granted U.S. Patent for Cannabinoid Technology to Overcome Antimicrobial Resistance such as MRSA |
| Jan 26, 2026 | finance.yahoo.com | SciSparc Successfully Completes Acquisition of IP Portfolio, Advances Toward Immediate Commercialization |
| Jan 13, 2026 | finance.yahoo.com | BC-Most Active Stocks |
| Jan 13, 2026 | finance.yahoo.com | SciSparc Signs Definitive Agreement to Acquire a Treasury of Patents for the Endoscope Market- Entering Multi-Billion Dollar Opportunity |
| Jan 12, 2026 | finance.yahoo.com | SciSparc Announces Receipt of Nasdaq Notification of Minimum Stockholders’ Equity Non-Compliance |
| Dec 30, 2025 | finance.yahoo.com | SciSparc: Neurothera Labs Granted Patent by Israeli Patent Office for its Proprietary Opioid-Based Patent Family to Enhance Pain Relief and Reduce Side Effects |
| Dec 30, 2025 | finance.yahoo.com | Neurothera Labs Granted Patent by Israeli Patent Office for Its Proprietary Opioid-Based Patent Family to Enhance Pain Relief and Reduce Side Effects |
| Dec 12, 2025 | www.prnewswire.com | IM Cannabis Appoints Asi Levi as Chief Financial Officer |
| Dec 2, 2025 | finance.yahoo.com | Neurothera Labs Signs Non-Binding Term Sheet to Acquire Majority Stake in a Quantum Algorithm Bio Data Analysis Company |
| Dec 2, 2025 | finance.yahoo.com | SciSparc: Neurothera Labs Signs Non-Binding Term Sheet to Acquire Majority Stake in a Quantum Algorithm Bio Data Analysis Company |
| Dec 1, 2025 | finance.yahoo.com | SciSparc Plans on Entering the Multi-Billion-Dollar GERD Device Market with Acquisition of an Approved IP Portfolio |
| Nov 26, 2025 | finance.yahoo.com | SciSparc to Acquire Treasury of Patents for Innovative Medical Endoscopy Systems |
| Nov 26, 2025 | finance.yahoo.com | BC-Most Active Stocks |
| Nov 20, 2025 | finance.yahoo.com | SciSparc: Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression |
| Nov 19, 2025 | finance.yahoo.com | Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression |
| Nov 17, 2025 | finance.yahoo.com | Clearmind Medicine Files Israeli Patent for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression |
| Oct 30, 2025 | finance.yahoo.com | N2OFF Completed Merger with Cancer Drug Discovery Company Targeting Tough-to-Treat Pancreatic and Lung Cancers |
| Oct 24, 2025 | finance.yahoo.com | SciSparc Announces Closing of the Acquisition of a Publicly Traded Company on the TSXV to which it transferred its Advanced Clinical Stage Pharmaceutical Portfolio |
| Oct 23, 2025 | finance.yahoo.com | SciSparc Targets Quantum-Powered 3D Protein Modeling Technology to Revolutionize AI Drug Discovery |
| Oct 23, 2025 | finance.yahoo.com | SciSparc Announces Closing of the Sale to N2OFF of Majority-Owned Subsidiary MitoCareX, Advancing Drug Discovery for Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer |
| Oct 15, 2025 | finance.yahoo.com | SciSparc Enters into Definitive Agreement for the Acquisition of a Publicly Traded Company on the TSXV to which it will transfer its Advanced Clinical Stage Pharmaceutical Portfolio |
| Oct 6, 2025 | finance.yahoo.com | SciSparc And AutoMax Call Off Merger |
| Oct 6, 2025 | finance.yahoo.com | SciSparc Ltd. Announces Framework Agreement Regarding Merger with AutoMax Motors |
| Sep 29, 2025 | finance.yahoo.com | SciSparc: N2OFF Shareholders Approve Merger with SciSparc’s Majority Owned Subsidiary MitoCareX, a Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer |
| Sep 25, 2025 | finance.yahoo.com | Top Midday Gainers |
| Sep 25, 2025 | finance.yahoo.com | N2OFF Stockholders Approve Merger with Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer |
| Sep 25, 2025 | finance.yahoo.com | SciSparc Resolves to Launch Innovative Quantum Computing-Enabled 3D Protein Modeling Initiative to Revolutionize AI Drug Discovery |
| Sep 17, 2025 | finance.yahoo.com | Wall Street Set to Open Little Changed Wednesday as Investors Anticipate Fed Rate Cut |
| Aug 28, 2025 | finance.yahoo.com | SciSparc: AutoMax’s Shareholders Approve Merger with SciSparc |
| Aug 28, 2025 | finance.yahoo.com | SciSparc Shareholders Approve Merger with a Leading Parallel Vehicle Importer in Israel |
| Aug 7, 2025 | finance.yahoo.com | Clearmind Medicine Announces Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar |
| Aug 7, 2025 | finance.yahoo.com | SciSparc-Clearmind Collaboration Leads to Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar |
| Jul 30, 2025 | finance.yahoo.com | SciSparc Announces Updates Regarding Proposed Merger; Form F-4 Registration Statement Has Been Declared Effective by SEC |
| Jul 30, 2025 | finance.yahoo.com | SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease |
| Jul 30, 2025 | finance.yahoo.com | Clearmind Medicine Files International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease |
| Jul 22, 2025 | finance.yahoo.com | SciSparc Ltd. Regains Compliance with Nasdaq Minimum Bid Price Notification |
| Jun 24, 2025 | finance.yahoo.com | SciSparc Announces 1-for-21 Reverse Share Split |
| May 27, 2025 | finance.yahoo.com | SciSparc Announces Publication of Japanese Patent Application |
| May 12, 2025 | finance.yahoo.com | Clearmind Medicine Announces Publication of European Patent for Psychedelic-Based Combination Therapy for Cocaine Addiction |
| May 12, 2025 | finance.yahoo.com | SciSparc-Clearmind Collaboration Leads to Publication of European Patent for Psychedelic-Based Combination Therapy for Cocaine Addiction |
| Apr 25, 2025 | finance.yahoo.com | SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders |
| Mar 10, 2025 | finance.yahoo.com | SciSparc-Clearmind Collaboration Leads to Publication of Patent Application for Cocaine Addiction Psychedelic Combination Treatment in South Korea |
| Mar 10, 2025 | finance.yahoo.com | Clearmind Medicine Announces Publication of Patent for Cocaine Addiction Psychedelic Combination Treatment in South Korea |
| Mar 3, 2025 | finance.yahoo.com | SciSparc Signs Definitive Agreement to Sell MitoCareX, Computational Drug Discovery Company Targeting Resistant Cancers |
| Feb 27, 2025 | finance.yahoo.com | SciSparc Extends $2 Million Loan to Support AutoMax's Growth Following AutoMax’s Entry into Direct Import of JAC Electric Vehicles |
| Feb 26, 2025 | finance.yahoo.com | N2OFF Signs Definitive Agreement to Acquire Next-Gen Computational Drug Discovery Company, Targeting Hard To Treat Cancers |
| Feb 18, 2025 | finance.yahoo.com | SciSparc Secures Favorable Settlement in Lawsuit It Filed, Receiving Cash Compensation and a Full Release from All Commitments, Royalties, and Allegations Asserted Against It on Claimed Core Technology |
| Feb 4, 2025 | finance.yahoo.com | SciSparc-Clearmind Collaboration Leads to Publication of Patent for Binge Behaviour Combination Treatment in Mexico |
| Jan 15, 2025 | finance.yahoo.com | SciSparc Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement |
| Jan 13, 2025 | finance.yahoo.com | SciSparc: AutoMax Enters the Direct Import Market with a $13 Million First Shipment of JAC Electric Vehicles |
| Jan 8, 2025 | finance.yahoo.com | SciSparc says MitoCareX expands research to pancreatic cancer |
| Jan 7, 2025 | finance.yahoo.com | SciSparc: MitoCareX Bio Expands Research to Pancreatic Cancer Following Initial In-Vitro Positive Results |
| Jan 6, 2025 | finance.yahoo.com | Why Is Psychedelic-SciSparc Stock Trading Higher On Monday? |
| Jan 6, 2025 | finance.yahoo.com | Sector Update: Health Care Stocks Edge Higher Premarket Monday |
| Jan 6, 2025 | finance.yahoo.com | SciSparc-Clearmind Medicine Collaboration Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment |
| Jan 2, 2025 | www.clinicaltrialsarena.com | IMCA renews SciSparc’s autism spectrum disorder therapy trial approval |
| Dec 31, 2024 | finance.yahoo.com | SciSparc Announces Renewal of Approval by Israeli Medical Cannabis Agency for its Clinical Trial in Children with Autism Spectrum Disorder |
| Dec 27, 2024 | finance.yahoo.com | SciSparc: AutoMax announces $13M first delivery of JAC vehicles |
| Dec 26, 2024 | finance.yahoo.com | SciSparc Shares Skyrocket With AutoMax's First JAC Motors Shipment |
| Dec 26, 2024 | finance.yahoo.com | SciSparc: AutoMax Announces $13 Million First Delivery of JAC Vehicles Following Regulatory Approval for Direct Importation |
| Dec 16, 2024 | finance.yahoo.com | SciSparc Provides Updates on Status of Spin-off of its Advanced Clinical Stage Pharmaceutical Portfolio to a Publicly Traded Company |
| Nov 30, 2024 | finance.yahoo.com | Jeffs’ Brands announces trademark registration approval for Wellution |
| Oct 1, 2024 | www.clinicaltrialsarena.com | SciSparc receives FDA approval for trial for Tourette syndrome therapy |
| Sep 30, 2024 | finance.yahoo.com | SciSparc Secures FDA Green Light to US Launch of its Pivotal Phase IIb Clinical Trial for Breakthrough Tourette Syndrome Treatment |
| Sep 26, 2024 | finance.yahoo.com | SciSparc Signs Non-Binding Letter of Intent to Sell Stake in MitoCareX |
| Sep 23, 2024 | finance.yahoo.com | SciSparc Receives FDA Approval to Initiate Phase IIb Clinical Trial for Tourette Syndrome Treatment |
| Sep 18, 2024 | finance.yahoo.com | SciSparc Takes Major Step Forward with IND Application submitted to the FDA for Phase IIb Clinical Trial for Tourette Syndrome Treatment |
| Sep 16, 2024 | finance.yahoo.com | SciSparc-Clearmind Medicine Collaboration Announces the Publication of an International Patent Application for Pioneering Ibogaine Combination Therapy |
| Sep 11, 2024 | finance.yahoo.com | SciSparc Advances $1.85 million Loan to AutoMax, Following AutoMax’s Direct Import Agreement with Major Chinese Vehicle Manufacturer |
| Sep 6, 2024 | finance.yahoo.com | SciSparc-Clearmind Medicine Collaboration Leads to Publication of International Patent Application for Innovative MDMA-Based Combination Treatment |
| Sep 6, 2024 | finance.yahoo.com | Clearmind Medicine Announces Publication of International Patent Application for Innovative MDMA-Based Combination Treatment |
| Aug 29, 2024 | finance.yahoo.com | SciSparc-Clearmind Medicine Collaboration Leads to Publication of Application for Innovative Ketamine-Based Combination |
| Aug 28, 2024 | finance.yahoo.com | SciSparc Grants Global Rights for Pain Therapy to Biotech Company in Agreement Worth up to $6 Million |
| Aug 26, 2024 | www.clinicaltrialsarena.com | SciSparc seeks FDA IND clearance for Phase IIb Tourette Syndrome treatment trial |
| Aug 26, 2024 | www.clinicaltrialsarena.com | SciSparc secures final approval in Israel to start Tourette’s Syndrome trial |
| Aug 23, 2024 | finance.yahoo.com | SciSparc Submitted IND Application to the FDA for SCI-110 Phase IIb Clinical Trial for Patients with Tourette Syndrome |
| Aug 22, 2024 | finance.yahoo.com | SciSparc: MitoCareX Appointed Professor Nir Peled, Seasoned Oncologist, to its Scientific Advisory Board |
| Aug 19, 2024 | www.pharmaceutical-technology.com | SciSparc and Polyrizon sign global agreement for pain therapy |
| Aug 19, 2024 | finance.yahoo.com | SciSparc Announces Enrollment of the First Five Patients in the Clinical Trial of its Innovative SCI-210 Treatment |
| Aug 16, 2024 | finance.yahoo.com | SciSparc Finalizes Exclusive Global Out-Licensing Agreement for its Pain Therapy Valued at $3 million |
| Aug 14, 2024 | finance.yahoo.com | SciSparc Updates Regarding the Status of the AutoMax Merger |
| Aug 6, 2024 | finance.yahoo.com | SciSparc’s Collaboration with Clearmind Medicine Continues to Bear Fruit With New Scientific Article Showing MEAI Potential as a Novel Weight Loss Drug |
| Jul 22, 2024 | finance.yahoo.com | SciSparc: MitoCareX Confirms Potential Significant Role of its Drug Target in Non-Small Cell Lung Cancer |
| Jul 17, 2024 | finance.yahoo.com | SciSparc Signs Non-Binding Letter of Intent for Exclusive Global Out-Licensing of Pain Treatment for Approximately $6 million |
| Jul 16, 2024 | finance.yahoo.com | SciSparc Ltd. Announces Receipt of Nasdaq Minimum Bid Price Notification |
| Jul 16, 2024 | finance.yahoo.com | SciSparc Announces U.S. Patent Application for Treating Metabolic Syndrome and Weight Loss |